China Risun (01907.HK) Interim 2026 Profit Surges 376%, New Energy Business Footprint Further Expanded, Interim Dividend Significantly Increased to RMB1.44 Cents per Share 
JF SmartInvest Holdings Ltd Announces 2026 Interim Results 
Xinyi Glass Announces Proposed Spin-off and Separate Listing of Its Automobile Glass Business 
Collaborate2Win campaign promotes Hong Kong’s professional services in Central Asia 
Galaxis Technology Announces 2026 Interim Results, Revenue Surges 45.1% YoY and Overseas Business Expansion Accelerates Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities
Dr. Michael Poole to Join the Board of Directors Dr. Claude Nicaise Appointed Head of…
Allena Pharmaceuticals, Inc. to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference
NEWTON, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical…
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021
GARDEN CITY, N.Y., July 08, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
CAMBRIDGE, Mass. and NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Today, access to the…
MYM Obtains Final Order for Arrangement with IM Cannabis Corp.
VANCOUVER, British Columbia, July 08, 2021 (GLOBE NEWSWIRE) — MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB:…
Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021
BALA CYNWYD, Pa., July 08, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Study Published in Nature Medicine Shows Investigational NASH Drug Reduced Liver Fat to Normal Levels and Reversed Fibrosis After 16 Weeks of Treatment
Efruxifermin (EFX) also improved markers of liver injury, inflammation, lipoproteins, and glycemic control SOUTH SAN…
iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021
CAMBRIDGE, Mass. and GOSSELIES, Belgium, July 08, 2021 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq:…
Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria
First Phase Launches Sky Premium Life Products on Amazon and eBay; Second Phase Launch Includes…
GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — GBS (Nasdaq: GBS), a life sciences company…
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer
MONTREAL, July 08, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
Todd Denkin to Return to the Digipath Helm
Founder and Past-President Tapped to Lead Digipath into Post-Pandemic Future LAS VEGAS, NV, July 08,…
Healthy Extracts Introduces Breakthrough Nutraceutical Formulation, Ultimate Brain Nutrients ACTIVATE™, Clinically Proven to Enhance Key Brain Activity by 46%
UBN ACTIVATE™ UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus,…
Albireo to Present at the William Blair Biotech Focus Conference 2021
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver…
Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
BURBANK, Calif., July 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused…
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR or the Company),…
Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021
WATERTOWN, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Amolyt Pharma Announces Appointment of Two Directors
Elisabeth Svanberg, M.D., Ph.D. brings extensive experience in the development of therapeutics for under-served endocrine,…